Novilytic Selected for 2025 BioTools Innovation Accelerator Program
- rsimpson473
- Jun 24
- 2 min read
WEST LAFAYETTE, Ind. (June 24, 2025) – Novilytic, an innovator in molecular recognition technology, is proud to announce its selection for the 2025 BioTools Innovator Accelerator, the first and only program focused exclusively on life science tools and diagnostics companies. Chosen from over 500 global applicants, Novilytic is one of only 31 startups to secure a place in this year’s esteemed cohort.
“Being selected for BioTools Innovator is an exciting step forward in the strategic growth of our organization,” said Paul Dreier, CEO of Novilytic. “The ability to collaborate with the newest generation of leaders and organizations in our industry will foster relationships and strategic planning steps that would have taken considerable time to achieve organically. This accelerated timeline in our growth aligns perfectly with our recent European product launch and expected patent news on the horizon.”
Novilytic’s flagship technology is its Proteometer platform, a series of kits that assist pharmaceutical companies in bringing new medicines to market faster by eliminating manual sample preparation. This advancement allows lifesaving medications to reach the market more quickly and cost-effectively.
BioTools Innovator provides a four-month accelerator program that includes personalized mentorship from senior industry leaders, opportunities to connect with investors, and networking events with peers and experts in the global life science community. At the end of the program, companies will compete for $300,000 in non-dilutive cash prizes.
About Novilytic
Novilytic is a leader in molecular recognition technology. Their Proteometer product line is revolutionizing drug development and clone selection by eliminating sample preparation steps that were previously industry-standard. Their transformational technology fundamentally changes biopharmaceutical production by providing near-real-time molecular structure analysis. This reduces the time and cost of new medicines, ultimately helping to bring lifesaving treatments to the market faster. For more information, visit Novilytic.com.
About BioTools Innovator
BioTools Innovator, based in Los Angeles, advances cutting-edge research and improves human health by accelerating the growth of life science tools and diagnostics startups. Powered by MedTech Innovator, the world’s largest accelerator for medical technology companies, BTI supports early-stage and emerging growth companies through mentorship, visibility, and non-dilutive funding opportunities. Learn more at biotoolsinnovator.org.
Media Contact:
Ryan Simpson, Director of Marketing, Novilytic, rsimpson@novilytic.com
###
###